Approval · Notice of Compliance 5081 · 1995
RHOVAIL: Notice of Compliance 5081
Issued September 14, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5081
- Date
- September 14, 1995
- Company
- Rho-Pharm Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-inflammatory, analgesic agent
Products in this notice
Medicinal ingredients
- KETOPROFEN 150 MG per CAP
- KETOPROFEN 200 MG per CAP